Overexpression of these MKK3-MYC signature genes has been linked with the induction of epithelial-to-mesenchymal transition in breast cancer and strongly correlates with worsened clinical outcomes in African American patients. The gene discussed is MAP2K3; the disease is breast carcinoma.